Department of Stomatology, General Hospital of Jinan Military Area Command, Jinan, Shandong 250031, China.
Med Hypotheses. 2013 Oct;81(4):729-30. doi: 10.1016/j.mehy.2013.07.037. Epub 2013 Aug 15.
Cheilitis granulomatosa is a rare disease characterised by the recurrent labial swelling of one or both lips with the possibility of the condition to remain on a permanent basis. This kind of granulomatous, inflammatory disease may appear independently or be linked to a paralysis such as the facial and lingua plicata which then characteristic of the Melkersson-Rosenthal syndrome. Classically, a non-necrotizing granulomatous inflammation is seen at histologic examination. Many treatments have been tried. But as its high recurrence rate, the results were often disappointing. The major active component of Pingyangmycin is bleomycin A5. Currently, bleomycin has been proved to be a widely accepted treatment protocol for hemangiomas and lymphangioma. It has been proved that bleomycin could infiltrate prominently into lymphocytes and other inflammatory cells. Stromal connective tissue would proliferate markedly as the result of sclerotherapy. Oedema, lymphangiectasia and perivascular lymphocytic infiltration are always seen in cheilitis granulomatosa histologically. Therefore, we hypothesize that intralesional injection of Pingyangmycin plus corticosteroids may be a safe and effective treatment for cheilitis granulomatosa. The efficacy of this treatment modality is worthy of further investigation.
肉芽肿性唇炎是一种罕见的疾病,其特征为单侧或双侧嘴唇反复肿胀,病情可能持续存在。这种肉芽肿性、炎症性疾病可能独立出现,也可能与面神经麻痹和(或)梅克尔憩室相关,而后者是梅尔基奥尔森-罗森塔尔综合征的特征。组织学检查可见非坏死性肉芽肿性炎症。已经尝试了许多治疗方法。但是,由于其高复发率,结果往往令人失望。平阳霉素的主要活性成分是博来霉素 A5。目前,博来霉素已被证明是治疗血管瘤和淋巴管瘤的广泛接受的治疗方案。已经证明博来霉素可以明显渗透到淋巴细胞和其他炎症细胞中。作为硬化治疗的结果,基质结缔组织会明显增殖。肉芽肿性唇炎的组织学表现为水肿、淋巴管扩张和血管周围淋巴细胞浸润。因此,我们假设平阳霉素联合皮质类固醇的病灶内注射可能是治疗肉芽肿性唇炎的一种安全有效的方法。这种治疗方式的疗效值得进一步研究。